Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Pediatr Radiol. 2011 Feb;41(2):141-3. doi: 10.1007/s00247-010-1777-5. Epub 2010 Aug 31.
To date, most molecular imaging techniques applied clinically have offered relatively general information about the metabolism and physiology of diseased cells and tissues. However, due to recent scientific and technological advances, much more specifically targeted molecular imaging probes (e.g., reporter gene probes, whole cell-tracking probes, and probes for localizing specific biomolecules) are now being used in preclinical research and, in some cases, translated to the clinical setting. As a result, the imaging community is poised to help lead a revolution in personalized, molecularly targeted medicine. This article considers the importance of molecular imaging for advancing research and clinical care both within individual institutions and across the medical field. It outlines specific steps that leaders in academic radiology can take to hasten progress in molecular imaging and explains why they must have the courage to reach across traditional interdisciplinary boundaries and advocate for major investments in equipment, education, and personnel.
迄今为止,大多数应用于临床的分子成像技术都提供了有关病变细胞和组织代谢和生理学的相对一般的信息。然而,由于最近的科学和技术进步,现在更多的具有特定靶向性的分子成像探针(例如,报告基因探针、全细胞追踪探针和定位特定生物分子的探针)正被用于临床前研究,并在某些情况下转化为临床应用。因此,成像界有望引领个性化、分子靶向医学的革命。本文考虑了分子成像在推进单个机构内和整个医学领域的研究和临床护理方面的重要性。它概述了学术放射学领导者可以采取的具体步骤,以加速分子成像的进展,并解释了他们为什么必须有勇气跨越传统的跨学科界限,倡导在设备、教育和人员方面进行重大投资。